Clinical trial
A Phase II, Multi-centre Study, of Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases From Non-small Cell Lung Cancer and Renal Cell Cancer
NCT02978404 is registered in ClinicalTrials.gov with Centre hospitalier de l'Université de Montréal (CHUM) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Multi-centre Study, of Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases From Non-small Cell Lung Cancer and Renal Cell Cancer
- Lead sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 2, 2017
- Completion date
- December 31, 2023
- Enrollment
- 26 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
brain metastases, adult, clear-cell metastatic renal cell carcinoma, melanoma, non small cell lung cancer metastatic, small cell lung cancer